Ascensión López-Dı́az de Cerio

Author

Also Known As

A L de Cerio, A Lopez-Diaz De Cerio, A López-Díaz de Cerio, A. L. de Cerio, A. L.-D. de Cerio, A. L.‐D. De Cerio, A. Lopez-Diaz de Cerio, A. Lòpez-Dìaz de Cerio, A. López-Diaz de Cerio, A. López-Díaz de Cerio

147

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Universidad de Navarra Clinica Universidad de Navarra Navarre Institute of Health Research Centro de Investigación Biomédica en Red de Cáncer Complejo Hospitalario de Navarra

About

Ascensión López-Dı́az de Cerio is an author at Universidad de Navarra specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.7K
2	Health Sciences	1	1	14
3	Natural Sciences	1	1	40
4	Public Health	1	1	32
5	Allergy	1	1	62

Ascensión López-Dı́az de Cerio

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma Kurt A. Schalper, María E. Rodríguez-Ruiz, Ricardo Díez-Valle, Nature Medicine Neuro-oncologyCancer ImmunosurveillanceMedicineImmunologyTumor Immunity	2019	642
CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-Primed CD4+ T Cells with IFN-γ-Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination Noëlia Casares, Laura Arribillaga, Pablo Sarobe, The Journal of Immunology	2003	190
Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma Maurizio Bendandi, Sylvestre Marillonnet, Romy Kandzia, Annals of Oncology VaccinationMolecular PharmingImmunologyBiotechnologyTherapeutic Vaccine	2010	186
Abnormal Priming of CD4<sup>+</sup>T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins Pablo Sarobe, Juan José Lasarte, Noëlia Casares, Journal of Virology	2002	162
Clinical Benefit Associated With Idiotypic Vaccination in Patients With Follicular Lymphoma Susana Inogés, Mercedes Rodrı́guez-Calvillo, Natalia Zabalegui, JNCI Journal of the National Cancer Institute	2006	148
Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients María E. Rodríguez-Ruiz, José Luis Perez‐Gracia, Inmaculada Rodríguez, Annals of Oncology	2018	137
IL‐10 suppressor activity and <i>ex vivo</i> Tr1 cell function are impaired in multiple sclerosis Iván Martínez‐Forero, Ricardo Garcı́a-Muñoz, Sara Martinez‐Pasamar, European Journal of Immunology T-regulatory CellImmunologyImmune RegulationImmunologic MechanismCd4 T Cell Responses	2008	134
Human Follicular Lymphoma Cells Contain Oligomannose Glycans in the Antigen-binding Site of the B-cell Receptor Catherine M. Radcliffe, James N. Arnold, David M. Suter, Journal of Biological Chemistry ImmunologyImmune RegulationPathologyImmunodominanceAntigen Processing	2006	133
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients Susana Inogés, Sonia Tejada, Ascensión López-Dı́az de Cerio, Journal of Translational Medicine	2017	130
CD28 Aptamers as Powerful Immune Response Modulators Fernando Pastor, Mario Martínez Soldevilla, Helena Villanueva, Molecular Therapy — Nucleic Acids	2013	122

Page 1